Clinical Trial Update: A Clinical Study of 6MW3211 in Patients With Renal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for 6MW3211 in advanced clear cell renal cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma

Drugs mentioned

• 6MW3211

Snippet

Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd. | Conditions: Advanced Clear Cell Renal Cell Carcinoma | Phase 2 | Status: UNKNOWN